(Q98754726)

English

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

An Adaptive Phase 1, Followed by Phase 2 Randomized, Double-blind, Multicenter Study to Evaluate the Safety, Reactogenicity, Tolerability, and Immunogenicity of the BBV152 in Healthy Volunteers, (English)

0 references

country

India

0 references

start time

13 July 2020

0 references

end time

30 June 2021

0 references

number of participants

1,125

0 references

clinical trial phase

phase I clinical trial

0 references

phase II clinical trial

0 references

Identifiers

ClinicalTrials.gov ID

NCT04471519

0 references

(Q98754726)

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)